Oyster Point Pharma, Inc. Deferred Costs, Noncurrent
Oyster Point Pharma, Inc. had Deferred Costs, Noncurrent of $2.12 million as of 2019-09-30, per its 10-Q filed 2019-12-03.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2019-12-03
- 2019-09-30: Deferred Costs, Noncurrent $2.12M.
- 2018-12-31: Deferred Costs, Noncurrent $0.00.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2019-09-30 | $2.12M 10-Q · filed 2019-12-03 |
| 2018-12-31 | $0.00 10-Q · filed 2019-12-03 |